CONMED Corporation (CNMD) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.

Total Revenue Chart for CONMED Corporation

CONMED Corporation (CNMD) revenue for FY2025 was USD 1.4B, a 5.2% change from FY2024. CONMED Corporation's revenue grew from USD 10.5M in 1986 to USD 1.4B in 2025 (12990.4% over 39 years). Earnings per share grew from USD 0.83 in 2000 to USD -2.68 in 2022 (-423.2%). Revenue compound annual growth rate: 5-year CAGR of 9.8%, 10-year CAGR of 6.7%, 20-year CAGR of 4.1%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$1.32B
Implied Share Price
$44.29
Enterprise Value
$2.13B
Revenue (TTM)
$1.37B
EBITDA
$214.97M
Profit Margin
5.36%
Trailing P/E
18.38
Forward P/E
27.17
Price/Book (MRQ)
1.29
Price/Sales (TTM)
0.96
EV/EBITDA
9.94
EV/Revenue
1.56
Dividend Yield
—
Book Value
$33.36
Free Cash Flow (FY2025)
$150.88M
Free Cash Flow Yield
11.43%

Snapshot as of 30th October 2026 — not point-in-time controlled, may lag the live market by a few days.